← Back to directory
N
Novaterra
Milan, Italy and LondonWebsite ↗
Novaterra is a venture capital firm founded in 2024, primarily based in Milan, Italy, and London. It positions itself as an evergreen investment holding company, utilizing a long-term, permanent capital approach to build and scale global industrial champions in critical technologies.
Last raised
Unknown
Latest fund size
—
AUM
—
Funds raised
Capital this firm has raised, newest first
No funds on record
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| GraphiCore | — | — | Jul 2025 | |
| Modulate Bio | Seed | $785K | Jul 2025 | |
| Piece | Seed | $3.8M | Apr 2025 | |
| Serenatis Bio | — | — | Apr 2025 | |
| Evaro | — | — | Jan 2024 | |
| Biocentis | Seed | $19M | Jan 2024 | |
| Ilios Therapeutics | Seed | — | Jun 2023 |
Sources
Where this data came from